The FINANCIAL -- Novo Nordisk on March 23 announced that the Japanese Ministry of Health, Labour and Welfare has approved...
The FINANCIAL -- On March 21, the European Commission conditionally approved Bayer’s proposed acquisition of Monsanto.
The FINANCIAL -- Johnson & Johnson on March 20 announced that Dominic J. Caruso, Executive Vice President, Chief Financial Officer,...
The FINANCIAL -- Johnson & Johnson on March 16 announced that it has received a binding offer from Platinum Equity,...
The FINANCIAL -- Roche announced on March 13 that its shareholders approved all proposals of the Board of Directors at...
The FINANCIAL -- Novartis announced on March 12 changes to its senior leadership team to support the implementation of its...
The FINANCIAL -- Astellas Pharma Inc. on March 1 announced that 40 mg XTANDI Tablets and 80 mg XTANDI Tablets...
The FINANCIAL -- The U.S. Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Application of...
The FINANCIAL -- Sanofi announced on March 1 that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976...
The FINANCIAL -- Roche on February 27 announced that the European Commission has approved Hemlibra (emicizumab) for routine prophylaxis of...
The FINANCIAL -- In 2017, Bayer’s operational business was at the prior-year level. The company made good progress strategically.
The FINANCIAL -- Merck on February 21 announced that the companies have signed a definitive agreement under which it is...
The FINANCIAL -- AstraZeneca and MedImmune, its global biologics research and development arm, on February 19 announced that the US...
The FINANCIAL -- Roche and Flatiron Health, Inc. announced on February 15 that the two partners have signed a definitive...
The FINANCIAL -- Roche and Ignyta, Inc. on February 8 announced that Roche’s wholly owned subsidiary Abingdon Acquisition Corp., has...